new glp 1 medications Eli Lilly to seek approval of GLP-1 weight-loss drug this year Swiss Re says GLP-1 drugs
Description
stated behavior
GLP-1 receptor agonists are typically initiated when lifestyle modifications and first-line oral antidiabetic agents (such as metformin) have not achieved adequate glycaemic control
How is it taken
(It is unclear when that will happen, but there is evidence it may not be far off: Novo Nordisk, which makes Wegovy and Ozempic using semaglutide, has recently increased supply of most dosages of the meds in the US.) The cost of drugs does not factor into whether they are in official shortage or not, but the affordability of these medications is directly connected to how accessible many patients find them
Varela ML, Mogildea M, Moreno I, Lopes A
Contact us today to learn more about GLP-1 medications and how they may fit into a comprehensive weight loss plan
